← Back to Clinical Trials
Recruiting NCT06989125

NCT06989125 Internet-based Versus Synchronous Cognitive Behavioural Therapy for Patients With Gambling Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06989125
Status Recruiting
Phase
Sponsor Aarhus University Hospital
Condition Gambling Disorder
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2025-02-24
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Internet-based cognitive behavioral therapySynchronous cognitive behavioral therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 150 participants in total. It began in 2025-02-24 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this two-armed, randomized controlled trial is to determine if internet-based cognitive behavioural therapy (CBT) is as effective as synchronous CBT (sCBT) for treating Gambling Disorder (GD) in adults. The main question it aims to answer is: Is the effect of the internet-based CBT ("SpilleFri") non-inferior to that of synchronous CBT in reducing gambling severity? The trial will enroll 150 patients with Gambling Disorder who will be randomized (1:1) to either the experimental condition (12 weeks' treatment with the internet-based treatment "SpilleFri") or the active control condition (18 weeks individual sCBT). The primary outcome measure will be based on self-reported GD severity (NODS). The trial will be considered effective if SpilleFri is not clinically inferior (within a predefined non-inferiority margin) to sCBT in reducing GD severity at the primary endpoint three months after end-of-treatment. In addition to evaluating the effectiveness of the treatments, the study will conduct an exploratory analysis of the impact of each condition on secondary outcomes (changes in gambling behavior, relationship quality, and symptoms of anxiety, depression, and emotional distress). Similarly, an exploratory analysis of process variables (gambling-related self-efficacy, maladaptive gambling cognitions, emotion regulation difficulties, and gambling urge) will be conducted across conditions and clinical subgroups. Participants will: * Engage in nine structured modules of either internet-based CBT or sCBT * Complete self-reported questionnaires on gambling severity and secondary symptoms at eight time points * Have the option for up to three additional support sessions with a psychologist

Eligibility Criteria

Inclusion Criteria: To be included patients should: * fulfil diagnostic criteria for GD (DSM-5). * score 4 points or more on the National Opinion Research Centre Screen for Gambling Problems (NODS). * be able to read, write, and speak Danish. * have IT skills and access to the internet and a computer, smartphone, and/or tablet. Exclusion Criteria: Patients are excluded from participation if they: * present with severe comorbid somatic disease, cognitive deficits, severe trauma, and/or psychiatric disorder (e.g. depression, bipolar disorder, substance abuse, ADHD) that is insufficiently treated at the time of assessment and/or is evaluated to constitute a barrier for engaging in or benefitting from treatment. * are not willing to engage in internet-delivered treatment or face-to-face cognitive behavioural therapy. * do not provide informed consent. * are in risk of suicide (indicated by clear intent and/or plans). * have previously received treatment via or had access to the SpilleFri platform. * seek treatment as part of an imminent legal case. * only fulfil diagnostic criteria for Gambling Disorder in relation to behaviour such as stock trading or buying and selling cryptocurrency. * present with highly unstable social circumstances, which are considered to potentially pose a barrier to engaging in treatment (e.g., homelessness).

Contact & Investigator

Central Contact

Anna W Stenbro, Master's degree in Psychology

✉ anna.stenbro@rm.dk

📞 +4541622166

Frequently Asked Questions

Who can join the NCT06989125 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Gambling Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06989125 currently recruiting?

Yes, NCT06989125 is actively recruiting participants. Contact the research team at anna.stenbro@rm.dk for enrollment information.

Where is the NCT06989125 trial being conducted?

This trial is being conducted at Aarhus, Denmark.

Who is sponsoring the NCT06989125 clinical trial?

NCT06989125 is sponsored by Aarhus University Hospital. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology